B

Biofourmis

565 employees

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Remote Patient Management
mHealth
Personal Health
Oncology
Cardiovascular
Post-acute Monitoring
Physiology Science
RPM
Therapeutics
Predictive Analytics
Hybrid Clinical Trial
Digital Therapeutics
Digital Health
Decentralized Clinical Trials
Physiology Monitoring

Date founded

2015

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

B

Biofourmis raised $20M on July 27, 2022

Investors: Intel Capital

B

Biofourmis raised $100M on September 3, 2020

Investors: Openspace Ventures, EDBI Pte Ltd and SoftBank Investment Advisers

B

Biofourmis raised $35M on May 21, 2019

Investors: JIANKE.COM (健客), Openspace Ventures, EDBI Pte Ltd and SGInnovate

B

Biofourmis raised $2M on May 1, 2018

Investors: SGInnovate

B

Biofourmis raised $5M on December 11, 2017

Investors: Openspace Ventures

B

Biofourmis raised $1M on August 10, 2016

Investors: Eden Strategy Institute, LLP.

B

Biofourmis raised $71K on December 1, 2015

Investors: Eden Strategy Institute, LLP.

FAQ